Why is Venus Remedies falling/rising?

As of 25-Aug, Venus Remedies Ltd is experiencing a decline in its stock price, currently at Rs 497.00, which represents a decrease of Rs 7.45 or 1.48%. Today's price summary indicates that the stock opened with a gain of 5% but has since fallen after three consecutive days of gains. The stock reached an intraday high of Rs 529.65 but also touched a low of Rs 490.05. Despite a strong year-to-date performance of 57.70% and a 39.63% increase over the past year, the stock has underperformed its sector by 1.89% today. Positive factors include a low debt-to-equity ratio, strong quarterly results, and increasing participation from institutional investors, which suggest a solid foundation for the stock. However, concerns about poor long-term growth, as indicated by modest net sales and operating profit growth rates, may be contributing to the current price decline.
In the broader market context, Venus Remedies has outperformed the benchmark Sensex in the short term, with a 1-week return of 3.23% compared to the Sensex's 0.45%. However, the stock's recent underperformance today may reflect a market correction after its previous gains, alongside the broader market's stability. The stock's liquidity remains adequate, which may help mitigate volatility, but the recent trend reversal and the decline in price could indicate investor caution in light of the company's slower long-term growth prospects.